货号:GS40817
Zeluvalimab (AMG-404) is an investigational human monoclonal antibody of the IgG1-kappa isotype that targets programmed cell death protein 1 (PD-1). It is being developed for cancer immunotherapy, aiming to block the interaction between PD-1 and its ligands PD-L1/PD-L2, thereby releasing T cells from inhibitory signals and enhancing anti-tumor immune responses.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物